Title:
CERVIAL CANCER-RELATED HPV E7 PROTEIN MONOCLONAL ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/045563
Kind Code:
A1
Abstract:
The present invention provides an anti-HPV E7 protein monoclonal antibody and the use thereof. The antibody can detect the HPV16 E7 protein with high specificity and recognize the HPV18 E7 protein, thereby it can distinguish between the cancerous cervical epithelial cells and the cervical abnormal or non-cancerous cervical epithelial cells.
Inventors:
CHANG XIAOJIA (CN)
SHI LIJUN (CN)
SHI CHENGLONG (CN)
HAN FENGLI (CN)
HUANG YAN (CN)
SHI LIJUN (CN)
SHI CHENGLONG (CN)
HAN FENGLI (CN)
HUANG YAN (CN)
Application Number:
PCT/CN2015/090139
Publication Date:
March 31, 2016
Filing Date:
September 21, 2015
Export Citation:
Assignee:
ATTOGEN BIOMEDICAL SUZHOU INC LTD (CN)
International Classes:
A61K39/42; C07K16/08; A61P35/00; C07K19/00; C12N15/13; C12N15/62; C12N15/63; G01N33/577
Domestic Patent References:
| WO2013038016A2 | 2013-03-21 | |||
| WO2011101122A1 | 2011-08-25 |
Foreign References:
| CN103254307A | 2013-08-21 | |||
| CN102443060A | 2012-05-09 |
Other References:
See also references of EP 3199548A4
Attorney, Agent or Firm:
XU & PARTNERS,LLC. (CN)
上海一平知识产权代理有限公司 (CN)
上海一平知识产权代理有限公司 (CN)
Download PDF: